4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-22-020717
Chief Executive Officer sold 30,000 shares at $12.20 ($366,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Violin Jonathan Chief Executive Officer | 2022-06-01 | Sale | −30,000 | $12.20 | $366,000 | 480,905 | D |
| Open-market sales · 30,000 sh · avg $12.20 · $366,000 | |||||||
Loading xslF345X03/doc4.xml…